Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could disrupt India's pharma industry, leading to higher prices and reduced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback